Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension
- PMID: 33471297
- PMCID: PMC7816058
- DOI: 10.1007/s40292-020-00429-3
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension
Abstract
The COVID-19 infection has rapidly spread around the world and a second wave is sweeping in many countries. Different clinical and epidemiological aspects characterize the disease and their understanding is necessary to better face the management of the pandemic in progress. The Italian society of arterial hypertension with the SARS-RAS study has contributed significantly to the knowledge of the interaction between inhibition of the renin-angiotensin system and COVID-19 infection. Furthermore, the study results help to understand some of the main aspects related to mortality and morbidity deriving from the infection through a multicentre analysis throughout the national territory.
Keywords: Anti-hypertensive therapy; Comorbidities; Frailty; Sars-Cov2; Sex-differences.
Conflict of interest statement
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Figures
References
-
- Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. Renin–angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the directors of the board and the scientific directors of the italian society of hypertension. High Blood Press Cardiovasc Prev. 2020;27:105–108. doi: 10.1007/s40292-020-00380-3. - DOI - PMC - PubMed
-
- Volpe M, Battistoni A, Board of the Italian Society of Cardiovascular P. Bellotti P, Bellone S, Bertolotti M, et al. Recommendations for cardiovascular prevention during the Sars-Cov-2 pandemic: an executive document by the board of the Italian Society of Cardiovascular Prevention. High Blood Press Cardiovasc Prev. 2020;27:373–377. doi: 10.1007/s40292-020-00401-1. - DOI - PMC - PubMed
-
- WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. In: Organization. WH editor. https://www.who.int/publications-detail/clinical-management-of-severeacu.... Accessed 28 Jan 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
